CILOSTAZOL ( DrugBank: Cilostazol )

3 diseases

46. 悪性関節リウマチ

臨床試験数 : 4,356 / 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05594680 (ClinicalTrials.gov)	November 1, 2022	18/10/2022	Cilostazol and Methotrexate in Rheumatoid Arthritis	The Phosphodiesterase 3 Inhibitor Cilostazol as Adjunct to Methotrexate in Patients With Rheumatoid Arthritis	Rheumatoid Arthritis	Drug: Cilostazol;Drug: Methotrexate;Drug: Placebo	Tanta University	NULL	Not yet recruiting	18 Years	60 Years	All	70	Phase 3	NULL
2	NCT05671497 (ClinicalTrials.gov)	November 1, 2022	14/12/2022	The Effect of Cilostazol on Rheumatoid Arthritis Patients	Evaluation of the Effect of Cilostazol on the Clinical Outcomes of Rheumatoid Arthritis Patients	Rheumatoid Arthritis	Drug: Cilostazol 100 MG;Drug: conventional synthetic antirheumatic drugs	Ain Shams University	Misr International University;Al-Azhar University	Recruiting	19 Years	N/A	All	70	Phase 2/Phase 3	Egypt

臨床試験数 : 525 / 薬物数 : 565 - (DrugBank : 148) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 217

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2010-019977-14-IT (EUCTR)	04/11/2010	27/12/2010	Efficacy of Cilostazol for the treatment of Raynaud’s Phenomenon in patients affected by Systemic Sclerosis - ND	Efficacy of Cilostazol for the treatment of Raynaud’s Phenomenon in patients affected by Systemic Sclerosis - ND	Patients affected by Systemic Sclerosis with Raynaud’s Phenomenon MedDRA version: 9.1;Level: LLT;Classification code 10042953	Trade Name: PLETAL INN or Proposed INN: CILOSTAZOL	AZIENDA OSPEDALIERA UNIVERSITARIA SAN MARTINO GENOVA	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes			Italy

臨床試験数 : 95 / 薬物数 : 169 - (DrugBank : 61) / 標的遺伝子数 : 68 - 標的パスウェイ数 : 90

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-UMIN000006588	2011/11/01	01/11/2011	Effect of antiplatelet agent on muscle cramps after surgery of lumbar spinal stenosis in patients with lumbar spinal canal stenosis and peripheral artery disease	Effect of antiplatelet agent on muscle cramps after surgery of lumbar spinal stenosis in patients with lumbar spinal canal stenosis and peripheral artery disease - Effect of antiplatelet agent on muscle cramps after surgery of lumbar spinal stenosis in patients with lumbar spinal canal stenosis and peripheral artery disease	Lumbar spinal canal stenosis	Continuous administration of cilostazol	Juntendo UniversityDepartment of Orthopaedic Surgery	NULL	Recruiting	Not applicable	Not applicable	Male and Female	30	Not applicable	Japan